Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Cybersecurity Efforts Emphasize Collaboration With Homeland Security Officials, Hospitals

This article was originally published in The Gray Sheet

Executive Summary

CDRH’s emergency preparedness director spelled out the device center’s cybersecurity efforts during a recent webinar. The efforts go beyond guidance and regulations and include proactive steps to tackle the challenge, including weekly meetings with the Department of Homeland Security, she said.

You may also be interested in...



FDA Outlines Agenda For Cybersecurity Workshop

Topics that will be addressed at an upcoming FDA cybersecurity meeting include postmarket management, risk assessment, the challenges of collaboration and developing cybersecurity standards.

Growing Concerns With Cybersecurity Hacks of Devices

While the agency released its first guidance on cybersecurity requirements a decade ago, a top FDA official says the agency has seen a spike in potential vulnerabilities over the past year and a half, and has been working with manufacturers and other stakeholders to fix them before someone gets hurt.

FDA Sticks With Premarket Plans In Cybersecurity Guidance

A final guidance issued by the agency on premarket submission content to support device cybersecurity is consistent with last year’s proposal. FDA was not swayed by calls to allow device firms to address cybersecurity risks and mitigation efforts within design history files rather than in premarket submissions.

Related Content

UsernamePublicRestriction

Register

MT032530

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel